Post-approval studies (Phase 4)Looking for participantsNCT06054035
What this trial is testing
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
Who this might be right for
Type2diabetesPreDiabetesRenal Failure
University Hospital Tuebingen 170